Levetiracetam: A practical option for seizure management in elderly patients with cognitive impairment

American Journal of Alzheimer's Disease and other Dementias

Volumn 25, Issue 2, 2010, Pages 149-154

  Lippa, Carol F ^a   Rosso, Andrea ^a   Hepler, Marjorie ^a   Jenssen, Sigmund ^a   Pillai, Jyoti ^a   Irwin, David ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimergs disease; Dementia; Epilepsy; Levetiracetam; Mild cognitive impairment; Seizure

Indexed keywords

ETIRACETAM;

ADULT; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE ASSESSMENT SCALE-COGNITIVE; ANOREXIA; ARTICLE; BALANCE DISORDER; BEHAVIOR; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE INTERVAL; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GERIATRICS; HEADACHE; HUMAN; INSOMNIA; MALE; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; PATIENT SATISFACTION; PHASE 4 CLINICAL TRIAL; SEIZURE; SIDE EFFECT; SUICIDAL IDEATION; TREATMENT DURATION; WEIGHT REDUCTION;

EID: 77749251909     PISSN: 15333175     EISSN: None     Source Type: Journal    
DOI: 10.1177/1533317508325095     Document Type: Article

References (23)

1. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol. 2003 ; 60: 1119-1122.
2. Ebly EM, Hogan DB, Parhad IM Cognitive impairment in the nondemented elderly. Results from the Canadian Study of Health and Aging. Arch Neurol. 1995 ; 52: 612-619.
3. Grundman M., Petersen RC, Ferris SH, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 ; 61: 59-66.
4. Ritchie K., Touchon J. Mild cognitive impairment: conceptual basis and current nosological status. Lancet. 2000 ; 355: 225-228.
5. Petersen RC, Doody R., Kurz A., et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001 ; 58: 1985-1992.
6. Mendez M., Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging. 1905 ; 20: 791-803.
7. Alsaadi TM, Koopmans S., Apperson M., Farias S. Levetiracetam monotherapy for elderly patients with epilepsy. Seizure. 2004 ; 13: 58-60.
8. Cramer JA, Leppik IE, Rue KD, Edrich P., Kramer G. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res. 2003 ; 56: 135-145.
9. Belcastro V., Costa C., Galletti F., Pisani F., Calabresi P., Parnetti L. Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. Eur J Neurol. 2007 ; 14: 1176-1178.
10. Patsalos PN Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 1905 ; 43: 707-724.
11. Patsalos PN The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol. 2003 ; 25: 123-129.
12. Briggs DE, French JA Levetiracetam safety profiles and tolerability in epilepsy patients. Expert Opin Drug Saf. 2004 ; 3: 415-424.
13. Arroyo S., Crawford P. Safety profile of levetiracetam. Epileptic Disord. 2003 ; 5 (suppl 1). S57 - S63.
14. French J., Edrich P., Cramer JA A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res. 2001 ; 47: 77-90.
15. Piazzini A., Chifari R., Canevini MP, Turner K., Fontana SP, Canger R. Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res. 2006 ; 68: 181-188.
16. Folstein MF, Folstein SE, McHugh PR "Mini-mental stategg. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 ; 12: 189-198.
17. Burch EAJ, Andrews SR Comparison of two cognitive rating scales in medically ill patients. Int J Psychiatry Med. 1987 ; 17: 193-200.
18. McRae C., Diem G., Vo A., OgBrien C., Seeberger L. Schwab & England: standardization of administration. Mov Disord. 2000 ; 15: 335-336.
19. Tariot PN, Mack JL, Patterson MB, et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimergs Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimergs Disease. Am J Psychiatry. 1995 ; 152: 1349-1357.
20. Miller RJ, Snowdon J., Vaughan R. The use of the Cohen-Mansfield Agitation Inventory in the assessment of behavioral disorders in nursing homes. J Am Geriatr Soc. 1995 ; 43: 546-549.
21. Jacobson MP Epilepsy in aging populations. Curr Treat Options Neurol. 2002 ; 4: 19-30.
22. Harms SL, Eberly LE, Garrard JM, Hardie NA, Bland PC, Leppik IE Prevalence of appropriate and problematic antiepileptic combination therapy in older people in the nursing home. J Am Geriatr Soc. 2005 ; 53: 1023-1028.
23. Sirven JI, Ozuna J. Diagnosing epilepsy in older adults: what does it mean for the primary care physician ? Geriatrics. 2005 ; 60: 30-35.